Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile

BACKGROUND: Clozapine is well known for its efficacy and clinical superiority compared to other antipsychotics in treatment-resistant schizophrenia (TRS). However, it is frequently underutilized worldwide because of its acute adverse events, as well as for its long-term cardiometabolic and hematolog...

Descripción completa

Detalles Bibliográficos
Autores principales: de Filippis, Renato, Gaetano, Raffaele, Schoretsanitis, Georgios, Verde, Giuseppe, Oliveti, Cesare Anthony, Kane, John M, Segura-Garcia, Cristina, De Fazio, Pasquale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257059/
https://www.ncbi.nlm.nih.gov/pubmed/34234440
http://dx.doi.org/10.2147/NDT.S312095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257059/
https://www.ncbi.nlm.nih.gov/pubmed/34234440
http://dx.doi.org/10.2147/NDT.S312095

Ejemplares similares